X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ALT

Closed

Altimmune Inc

4.23
+0.36 (+9.30%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 3.87
Day's Range: 3.77 - 4.23
Send
When Written:
 
4.22
Altimmune Inc is a clinical-stage biopharmaceutical company that focuses on developing vaccines and therapeutics for infectious diseases and immune-mediated disorders. The company's lead product candidate is NasoVAX, a single-dose intranasal vaccine for influenza. Altimmune's other product candidates include AdCOVID, a single-dose intranasal vaccine for COVID-19, and HepTcell, a therapeutic vaccine for chronic hepatitis B. The company also has a pipeline of preclinical candidates for cancer immunotherapy and respiratory diseases. Altimmune is headquartered in Gaithersburg, Maryland, and was founded in 1997.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X